E-LIB Suche - Ergebnisse für: Wierzbicki, R

1

Madelung's disease – progressive, excessive, and symmetrica..:

Szewc M ; Sitarz R ; Moroz N..
https://www.dovepress.com/madelungs-disease-progressive-excessive-and-symmetrical-deposition-of-peer-reviewed-article-DMSO. , 2018

Link: https://doaj.org/article..

2

First-Line Crizotinib versus Chemotherapy in ALK-Positive L..:

Solomon, Benjamin J ; Mok, Tony ; Kim, Dong-Wan...
New England Journal of Medicine, Vol.371 No.23, pp.2167-2177. , 2014

Link: http://hdl.handle.net/10..

3

Quality of Life Analysis of TORCH, a Randomized Trial Testi..:

Di Maio M ; Leighl NB ; Gallo C...
info:eu-repo/semantics/altIdentifier/pmid/23154555. , 2012

Link: http://hdl.handle.net/11..

4

Randomized Trial of a Vaccine Regimen to Prevent Chronic HC..:

Page, Kimberly ; Melia, Michael T ; Veenhuis, Rebecca T...
qt9n00b25c. , 2021

Link: https://escholarship.org..

5

Resistance-Guided Treatment of Gonorrhea: A Prospective Cli..:

Klausner, Jeffrey D ; Bristow, Claire C ; Soge, Olusegun O...
qt1dp7453n. , 2021

Link: https://escholarship.org..

6

Randomized Trial of a Vaccine Regimen to Prevent Chronic HC..:

Page, Kimberly ; Melia, Michael T ; Veenhuis, Rebecca T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367093/. , 2021

Link: http://www.ncbi.nlm.nih...

7

Performance of a single-use, rapid, point-of-care PCR devic..:

Morris, Sheldon R ; Bristow, Claire C ; Wierzbicki, Michael R...
qt6h74909q. , 2021

Link: https://escholarship.org..

8

A Cross Sectional Study of Performance of a single use rapi..:

Morris, Sheldon R ; Bristow, Claire C ; Wierzbicki, Michael R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884536/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Randomized Trial of Lactin-V to Prevent Recurrence of Bacte..:

Cohen, Craig R ; Wierzbicki, Michael R ; French, Audrey L...
qt63d236n5. , 2020

Link: https://escholarship.org..

10

Randomized Trial of Lactin-V to Prevent Recurrence of Bacte..:

Cohen, Craig R ; Wierzbicki, Michael R ; French, Audrey L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362958/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Impact of eligibility criteria on participant enrollment fo..:

Long, Jill E ; Wierzbicki, Michael R ; Hook, Edward W
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431289/. , 2017

Link: http://www.ncbi.nlm.nih...

12

Development of Abbreviated Eight-Item Form of the Penn Verb..:

Bilker, Warren B ; Wierzbicki, Michael R ; Brensinger, Colleen M..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

13

First-line crizotinib versus chemotherapy in ALK-positive l..:

B. J. Solomon ; T. Mok ; D. W. Kim...
info:eu-repo/semantics/altIdentifier/pmid/25470694. , 2014

Link: http://hdl.handle.net/24..

14

Testing branching process estimators of cascading failure w..:

Dobson, Ian ; Kim, Janghoon ; Wierzbicki, Kevin R
qt0x79r392. , 2010

Link: https://escholarship.org..

15

Performance Analysis of the National Early Warning Score an..:

Christopher J. Colombo, MD, MA, FACP, FCCM ; Rhonda E. Colombo, MD, MHS, FACP, FIDSA ; Ryan C. Maves, MD, FCCM, FCCP, FIDSA...
http://journals.lww.com/10.1097/CCE.0000000000000474. , 2021

Link: https://doi.org/10.1097/..